Vertex stock falls after FDA halts diabetes study in surprise move - The Boston Globe

Diabetes Tips, News & Articles

Vertex Pharmaceuticals shares tumbled after US regulators placed its study of a key new treatment for type 1 diabetes on clinical hold.
Vertex Pharmaceuticals shares tumbled after US regulators placed its study of a key new treatment for type 1 diabetes on clinical hold.
Read more
Note: This news content is auto-generated from a syndicated feed.

If you have a family history of diabetes you could be at risk, get tested now! Book Diabetes test online

Popular posts from this blog

How the timing of dinner and genetics affect individuals' blood sugar control - ScienceDaily

Coronapod: COVID and diabetes, what the science says - Nature

Sciwind Biosciences Announces Initiation of Dosing in Phase 1 Clinical Trial Evaluating ...